The calcium awakens: new insights in cardiac gene therapy. [PDF]
Santulli G.
europepmc +1 more source
Reactive species generated by a cold atmospheric plasma inactivate AAV through oxidative and nitrosative stress. [PDF]
Lavrikova AY +5 more
europepmc +1 more source
Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels. [PDF]
Herbst K +8 more
europepmc +1 more source
First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3-associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1. [PDF]
Desai MY +17 more
europepmc +1 more source
CRISPR-Cpf1-Mediated Gene-Editing System Based on a Single Bidirectional Promoter. [PDF]
Kim S +6 more
europepmc +1 more source
Insertion-Site Proximity to AAV Inverted Terminal Repeats Increases Plasmid Recombination. [PDF]
Makarenko M, Semicheva D, Fishman V.
europepmc +1 more source
Modified Plasmids and Inverted Terminal Repeats Enhance Adeno-Associated Virus Production and Performance. [PDF]
Donohue N +5 more
europepmc +1 more source
Exploration of genes and identification of evolutionary evidence in adeno-associated viruses. [PDF]
Lee C +10 more
europepmc +1 more source
Adeno-Associated Virus Gene Therapy: Is There a Risk of Insertional Mutagenesis? [PDF]
Batty P.
europepmc +1 more source
Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A. [PDF]
Raheja P +9 more
europepmc +1 more source

